← Back to Patent Explorer
US5002873A Expired / Lapsed US ⏱️ 0.0 years remaining

DNA sequence encoding a lymphocyte adhesion receptor for high endothelium

Assignee: Fred Hutchinson Cancer Center
•
Filing: 1989-03-17
•
Granted: 1991-03-26
•
Expires: 2009-03-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A lymphoid cell line cDNA that encodes an adhesion receptor for high endothelial venules (HEV).

Inventors

  • 👤 Thomas P. St. John
  • 👤 W. Michael Gallatin
  • 👤 Rejean L. Idzerda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 18:03
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/705; C07K14/70503; C07K14/70532; A; A61; A61P; A61P31/00; C07K14/70585; C07K16/00; C07K16/18; C07K16/28; C07K16/2884; A61K; A61K38/00; C07K2319/00; C07K2319/32; C07K2319/61; Y; Y10; Y10S; Y10S530/00; Y10S530/806

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 32 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 182 and 1207 inclusive of the baboon lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 2
Dependent Claim 32 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 182 and 1207 inclusive of the baboon lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 3
Dependent Claim 35 words
The isolated DNA molecule of claim 1, which encodes for a polypeptide that is recognized by a binding partner specific for a glycoprotein lymphocyte surface receptor for high-walled endothelial venule (HEV) determinants in postcapillary venules.
Claim 4
Dependent Claim 28 words
The isolated DNA molecule of claim 1, which encodes for a polypeptide that is recognized by a binding partner specific for the Class III extracellular matrix receptor (ECMRIII).
Claim 5
Dependent Claim 24 words
The isolated DNA molecule of claim 1, which encodes for a polypeptide that is recognized by a binding partner specific for the CD44 molecule.
Claim 6
Dependent Claim 41 words
The isolated DNA molecule of claim 1, capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 182 and 991 inclusive of the extracellular and transmembrane domains of the baboon lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 7
Dependent Claim 38 words
The isolated DNA molecule of claim 1, capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 182 and 931 inclusive of the extracellular domain of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 8
Dependent Claim 35 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 932 and 991 inclusive of the transmembrane domain of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 9
Dependent Claim 35 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 932 and 991 inclusive of the transmembrane domain of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 10
Dependent Claim 37 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 932 and 1207 inclusive of the transmembrane and cytoplasmic domains of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 11
Dependent Claim 37 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 932 and 1207 inclusive of the transmembrane and cytoplasmic domains of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 12
Dependent Claim 35 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 992 and 1207 inclusive of the cytoplasmic domain of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 13
Dependent Claim 35 words
An isolated DNA molecule capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 992 and 1207 inclusive of the cytoplasmic domain of the lymphocyte adhesion receptor gene shown in FIG. 4.
Claim 14
Dependent Claim 22 words
A recombinant expression vector comprising at least one strand of the DNA molecule of claim 1 operably linked to suitable control sequences.
Claim 15
Dependent Claim 10 words
Cells transfected with the recombinant expression vector of claim 10.
Claim 16
Dependent Claim 46 words
A method of producing a polypeptide that is recognized by a binding partner specific for a lymphocyte surface receptor for high-walled endothelial venule (HEV) determinants in postcapillary venules, the method comprising culturing the cells of claim 11 under conditions effective for the production of said polypeptide.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-03-25 1994-09-24 1995-03-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-03-25 1998-09-24 1999-03-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-03-25 2002-09-24 2003-03-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag